✦ LIBER ✦

Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?

✍ Scribed by Seung Tae Kim, Jae Sook Sung, Uk Hyun Jo, Kyong Hwa Park, Sang Won Shin, Yeul Hong Kim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR and KRAS mutational profiling in fr

✍ Giulia M. Stella, Roberta Scabini… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 464 KB

9136 POSTER Can Serum Be Used for Analyz

✍ Kim, S.; Jung, H.; Sung, J.; Jo, U.; Kim, Y.; Shin, S.; Tanaka, T.; Hagiwara, K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

EGFR, ERBB2, and KRAS mutations in Korea

✍ Nack Cheon Bae; Myung Hwa Chae; Myung Hoon Lee; Kyung Mee Kim; Eung Bae Lee; Cha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Detection of EGFR and KRAS mutations in

✍ Board, R.; Shah, R.; Priest, L.; Bishop, P.; Ranson, M.; Hughes, A.N.; Dive, C.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

EGFR mutations in patients with non-smal

✍ S. Ricciardi; B. Tedesco; M.R. Migliorino; P. Graziano; A. Leone; M. Di Salvia; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Frequency of EGFR and KRAS mutations in

✍ Bauml, Joshua; Mick, Rosemarie; Zhang, Yu; Watt, Christopher D.; Vachani, Anil; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 620 KB